37.15 - 38.24
22.75 - 39.30
1.11M / 91.9K (Avg.)
12.71 | 2.99
Analyze analyst forecasts for the company and compare them with competitors.
7.11M
The estimated revenue has increased from the previous period.
3.24M
The estimated EBITDA has increased from the previous period.
-1.56
The estimated EPS has decreased from the previous period.
-310.95M
The estimated net income has decreased from the previous period.
1.72M
The estimated EBIT has increased from the previous period.
435.39K
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
376.93M
Revenue has increased from the previous period.
186.06%
Revenue growth rate has increased from the previous period.
235.60M
EBITDA has increased from the previous period.
62.50%
EBITDA margin has increased from the previous period.
169.41M
EBIT has increased from the previous period.
44.95%
EBIT margin has increased from the previous period.
66.19M
Depreciation has increased from the previous period.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
45.83M
Receivables have increased from the previous period.
12.16%
Receivables percentage has decreased from the previous period.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
35.64M
Accounts payable has increased from the previous period.
9.46%
Payables percentage has decreased from the previous period.
-191.36M
Capital expenditure has increased from the previous period.
-50.77%
CapEx percentage has decreased from the previous period.
13.98%
WACC has decreased from the previous period.
18.00%
Cost of equity is unchanged from the previous period.
7.81%
Cost of debt is unchanged from the previous period.
2.84
Beta is unchanged from the previous period.
199.90M
Diluted shares outstanding is unchanged from the previous period.
3.07B
Total debt is unchanged from the previous period.
6.21B
Total equity is unchanged from the previous period.
9.28B
Total capital is unchanged from the previous period.
33.09%
Debt weighting is unchanged from the previous period.
66.91%
Equity weighting is unchanged from the previous period.
127.22M
EBIAT has increased from the previous period.
-59.66M
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
-167.53B
Terminal value is unchanged from the previous period.
-110.28B
Enterprise value has decreased from the previous period.
3.09B
Net debt is unchanged from the previous period.
-113.37B
Equity value has decreased from the previous period.
-567.15
Equity value per share has decreased from the previous period.